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Abstract: This paper reports the isolation and structural characterization of four new ent-kaurane
derivatives from the Lamiaceae plant Sideritis hyssopifolia. Planar structures and relative configurations
were determined using both mass spectrometry and nuclear magnetic resonance (1D and 2D).
Absolute configurations were determined by comparing experimental and theoretical electronic
circular dichroism spectra. The cytotoxic and microbial activities of all new compounds were tested.
Compounds that were non-cytotoxic were further evaluated for anti-inflammatory activity.
Keywords: Sideritis hyssopifolia; ent-kaurane; anti-inflammatory; NMR
1. Introduction
The cosmetics sector represents a huge potential for growth in today’s society. The quest for
wellness and beauty has led to an intensive search for new products that can improve both the
appearance and hygiene of an aging population. In this context, an increasing number of cosmetic
companies are using nature as a unique source for their formulations. To discover new compounds
of interest, the French company Laboratoires Clarins has been conducting an in-depth investigation
of plants in their unique outdoor fields situated in the French Alps. Sideritis, containing around 190
species, is a widespread genus of the family Lamiaceae, which is commonly found in the Northern
Hemisphere [1]. Around 250 natural products have been reported from the genus Sideritis, of which
160 are in the diterpene class, specifically in the kaurane group [2,3]. These kauranes and their
enantiomers, ent-kauranes, exhibit a wide range of bioactivities, with antioxidant, anti-tyrosinase,
anti-cholinesterase, and anti-inflammatory properties reported [4–6]. The focus of this study was
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the species Sideritis hyssopifolia grown in the French Alps. The phytochemical composition of this
species is poorly described, with only two publications reporting the isolation and characterization
of its flavonoids and its essential oil composition [7,8]. Except for siderol [9], diterpenoids have yet
to be reported in S. hyssopifolia [10]. Because these compounds are commonly found throughout the
Sideritis genus, we re-investigated the phytochemical composition of S. hyssopifolia and, as a result,
isolated 12 compounds, eight of which are reported in this species for the first time, namely, siderol
[9], sideridiol [9], siderone [11], ent-kaurene I [12], sideritriol [13], ent-15β,16β-epoxykauran-18-ol [14],
epi-candicandiol [12], and ent-3β-7α-dihydroxykaur-16-ene [15]. Additionally, four new ent-kauranes
were fully characterized (Figure 1) using 1D and 2D NMR, MS, and ECD. The four novel compounds
were evaluated for their cytotoxic, antimicrobial, and anti-inflammatory activities.
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Figure 1. Structure of the new ent-kauranes compounds 1–4.
2. Results and Discussion
Compound 1 was isolated as a light yellow oil. Its molecular formula was determined from the
[M+H]+ observed at m/z 305.2481 (calculated for C20H33O2, 305.2475, δ 1.9 ppm) in the HRESIMS
spectrum acquired in positive ionization mode; the formula required five degrees of unsaturation in
the molecule. The 1H NMR spectrum exhibited four methyl singlets at δ 0.76 (s, 3H, H3-18), 0.95 (s, 3H,
H3-19), 1.07 (s, 3H, H3-20), and 1.71 (s, 3H, H3-17) ppm (Table 1 and 2). A signal corresponding to a
trisubstituted double bond at δ 5.52 (s, 1H, H-15) was also observed, together with two hydroxylated
methines at δ 3.17 (dd, J = 11.6, 4.5 Hz, 1H, H-3) and 3.54 (br s, 1H, H-7). Inspection of the 1H–1H COSY
spectrum led to the identification of three spin systems. The first one started with a clear correlation of
H-3 with H-2a δ 1.67 (m, 1H) and H-2b δ 1.60 (m, 1H), which, in turn, correlated with the methylene
protons H-1 at δ 1.84 (1H, m) and 0.95 (1H, m). A second spin system was observed between H-7 and
H-6 δ 1.66 (m, 1H) and 1.62 (m, 1H), and the last correlation was observed between H6b and H-5 at δ
1.40 (d, J = 12.0 Hz, 1H). A last spin system comprising H-9/H-11/H-12/H-13/H-14 was identified,
with correlations between δ 1.28 (d, J = 4.7 Hz, 1H, H-9), 1.54 (m, 2H, H2-11), 1.51 (m, 2H, H2-12),
2.33 (br s, 1H, H-13), and 1.96 (d, J = 9.9 Hz, 1H, H-14a). A 4J cross-peak between H-15 and H-17
was also observed. Analysis of the HMBC spectrum revealed a connection between the three spin
systems. The correlations of H-20 with C-1/C-5/C-9 and H-18/H-19 with C-3/C-5 indicated the
presence of the first decalin ring. Two other cycles were identified using intense 2J correlations between
H-7/H-9/H-14/H-15 and C-8. The last cycle was confirmed by the cross-peak between H-13 and C-16.
The full three-dimensional structure was determined using the coupling constant values of the 1H
NMR spectra and the NOESY correlations (see Figure 2).
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Table 1. 1H NMR data of compounds 1–4 (1H 500 MHz).
1a 2b 3b 4b
No. δH (m, J in Hz) δH (m, J in Hz) δH (m, J in Hz) δH (m, J in Hz)
1a 1.84 (dt, 13.0, 3.5) 1.82 (dt, 13.2, 3.5) 1.84 (m) 1.84 (m)
1b 0.95 (m) 1.03 (m) 1.05 (td, 13.0, 4.0) 1.07 (dd, 12.5, 3.6)
2a 1.67 (m) 1.70 (m) 1.69 (m) 1.65 (m)
2b 1.60 (m) 1.62 (m) 1.64 (m) 1.52 (m)
3a 3.17 (dd, 11.6, 4.5) 4.52 (dd, 11.6, 5.1) 4.53 (dd, 11.6, 5.0) 1.55 (m)
3b - - - 1.27 (dd, 14.3, 5.5)
4 - - - -
5 1.40 (d, 12.0) 1.49 (m) 1.55 (m) 1.86 (m)
6a 1.66 (m) 1.65 (m) 1.68 (m) 1.74 (dd, 14.4, 3.8)
6b 1.62 (m) 1.56 (m)
7 3.54 (bs) 3.63 (t, 2.9) 3.62 (t, 3.1) 4.82 (t, 3.0)
8 - - - -
9 1.28 (d, 4.7) 1.30 (d, 7.5) 1.42 (d, 6.6) 1.86 (m)
10 - - - -
11 1.54 (m) 1.49 (m) 1.56 (m) 5.36 (dd, 9.7, 3.5)
12a 1.51 (m) 1.49 (m) 1.70 (m) 6.25 (dd, 9.6, 6.5)
12b 1.49 (m) -
13 2.33 (bs) 2.37 (bs) 2.68 (m) 2.56 (m)
14a 1.96 (d, 9.9) 1.89 d (10.1) 1.82 (m) 2.01 (d, 9.4)
14b 1.35 (dd, 10.1, 5.3) 1.36 (d, 10.2, 5.2) 1.17 (dd, 11.4, 5.0) 1.50 (m)
15 5.52 (s) 5.47 (s) 2.25 (bs) 5.09 (s)
16 - - - -
17a 1.71 (s) 1.72 (bs) 4.83 (bs) 1.77 (d, 1.1)
17b - - 4.80 (bs) -
18 0.96 (s) 0.84 (s) 0.88 (s) 0.72 (s)
19a 0.76 (s) 0.85 (s) 0.86 (s) 3.36 (d, 10.8)
19b - - - 3.04 (d, 10.8)
20 1.07 (s) 1.05 (s) 1.05 (s) 1.04 (s)
21 - - - -
22 - 2.04 (s) 2.04 (s) 2.09 (s)
a CD3OD, b CDCl3.
The multiplicity of the signal at δ 3.17 (dd, J = 11.6, 4.5 Hz, 1H, H-3) indicated an axial orientation
for H-3. The NOESY correlations between H-5/H-3 and H-5/H-9 confirmed the relative configuration
of C-5 and the trans ring junction. The position of the trisubstituted double bond was supported by
the NOESY correlation between H-15/H-9 and the correlation between H-14/H-20. Finally, the broad
singlet signal for H-7 indicated a α orientation at C-7. This was further confirmed by the correlation
between H-7/H-14b.
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Figure 2. (A) COSY correlations; (B) HMBC key correlations; and (C) NOESY correlations.
The absolute configuration was determined by comparing experimental and theoretical electronic
circular dichroism (ECD) spectra. As expected, the spectrum (Figure 3) revealed only one Cotton Effect
(CE), which was due to the pi→ pi∗ transition. The sign of the CE agreed with compound 1 belonging
to the ent-kaurane series. This compound was named hyssopifoliol A.
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Figure 3. Comparison between experimental and theoretical ECD spectra of compound 1.
Compound 2 was isolated as a light yellow oil. Its molecular formula was determined from
the [M-AcOH+H]+ observed at m/z 287.2361 (calculated for C20H31O, 287.2369, ∆ −2.8 ppm)
in the HRESIMS spectrum acquired in positive ionization mode. Inspection of the 1H NMR spectrum
suggested that compound 2 was very similar to compound 1 since only one additional signal, which
was easily assigned to an acetyl moiety, was found at δ 2.04 (s, 3H, H3-22) ppm. This was confirmed by
the deshielding of the H-3 signal at δ 4.52 (dd, J = 11.6, 4.6 Hz, 1H, H-3) and the HMBC correlation
between H-3 and C-21. The three-dimensional structure appeared to be similar to that determined
for compound 1 because the coupling constants observed for the critical signals did not change. The
multiplicities were similar with a doublet of doublets at δ 4.52 (dd, J = 11.6, 4.5 Hz) and 3.63 (J =
2.9 Hz) ppm for H-3 and H-7, respectively. The relative configurations at C-5, C-8, and C-9 were
established using the correlations in the NOESY spectrum (see supporting information). The absolute
configuration of compound 2 was determined by comparing the sign of the unique CE on the ECD
spectrum. As for compound 1, the positive band at ca. 215 nm led to the conclusion that compound 2
was an ent-kaurane and was named hyssopifoliol B.
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Table 2. 13C NMR data of compounds 1–4 (13C 125 MHz).
1a 2b 3b 4b
No. δC δC δC δC
1 40.1 38.4 38.4 39.2
2 28.1 23.6 23.8 17.9
3 79.8 80.8 81.0 35.1
4 39.4 37.2 37.4 37.1
5 46.1 45.1 45.6 38.8
6 27.7 26.7 27.4 23.9
7 76.2 75.0 77.2 78.0
8 54.5 53.3 48.3 50.5
9 45.2 43.7 50.3 50.9
10 40.3 39.1 38.9 38.8
11 19.6 18.4 18.0 126.1
12 25.9 24.8 33.7 134.4
13 46.1 44.7 43.9 45.5
14 43.5 42.1 38.6 40.2
15 131.9 129.7 45.8 126.6
16 144.2 144.3 154.9 154.0
17 15.5 15.5 103.8 15.9
18 162 16.6 16.9 17.6
19 28.6 28.0 28.3 71.3
20 18.2 17.6 17.6 17.5
21 - 170.9 171.1 170.5
22 - 21.3 21.5 21.5
a CD3OD, b CDCl3.
Compound 3 was isolated as a light yellow oil. Its molecular formula was determined from the
[M+H]+ observed at m/z 347.2786 (calculated for C22H34O3Na, 347.2780, δ +1.7 ppm) in the HRESIMS
spectrum acquired in positive ionization mode; the formula required 6 degrees of unsaturation in the
molecule. The 1H NMR spectrum exhibited four methyl singlets at δ 0.86 (s, H3-18), 0.86 (s, H3-19),
1.05 (s, 3H, H3-20), and 2.04 (s, 3H, H3-22) ppm. The signal at 4.49 (dd, J = 11.4, 5.2 Hz) is typical of an
axial acetylated methine at H-3, and a broad singlet assigned to a hydroxylated methine at H-7 was
observed at δ 3.62 (t, J = 3.1 Hz, 1H, H-7). A major difference was observed between compounds 2
and 3: two broad one-proton singlets at δ 4.76 and 4.80 ppm were observed in the 1H NMR spectrum,
while the singlet at δ 1.71 was absent. This difference was attributed to the isomerization of the
double bond to obtain an exo-methylene group (H2-17). The relative configuration was conserved
between compounds 2 and 3, and the multiplicities of the key stereogenic centers were very similar
for both compounds (see Table 1). The relative configuration of 3 was confirmed by saponification
(K2CO3/MeOH). The 1H NMR spectrum of the resulting diol compound was compared with the
published spectrum of ent-3β-7α-dihydroxykaur-16-ene [15], and a perfect match was obtained, thus
confirming the relative configuration of compound 3. According to the sign of the CE on ECD
spectrum, the same absolute configuration was attributed to compound 3. Compound 3 was thus
named 3-acetoxy-ent-3β-7α-dihydroxykaur-16-ene.
Compound 4 was isolated as a light yellow oil. Its molecular formula was determined from
the [M-AcOH+H]+ observed at m/z 285.2251 (calculated for C20H29O, 285.2221, δ 10.5 ppm) in the
HRESIMS spectrum acquired in positive ionization mode; the formula required seven degrees of
unsaturation in the molecule. This additional unsaturation was quickly identified in the 1H NMR
spectrum as two olefinic signals at δ 5.36 (dd, J = 9.7, 3.5 Hz, 1H, H-11) and 6.25 (dd, J = 9.6, 6.5
Hz, H-12). The core of compounds 1 and 2 was conserved, but a methyl singlet was missing, and
two oxygenated geminal protons were observed at δ 3.36 (d, J = 10.8 Hz, H-19a) and 3.04 (d, J =
10.8 Hz, 1H, H-19b). Oxidation at C-19 was confirmed by the HMBC correlations between H-19 and
C-3/C-4/C-5/C-18. The acetyl group was positioned at C-7, as determined by the deshielding of H-7.
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This was further confirmed by the cross-peak at H-7/C-21 in the HMBC spectrum. Compound 4 was
named 11,12-didehydrosiderol.
After an evaluation of the purity of the compounds, compounds 1 (97%), 3 (95%) and
4 (87%) were tested for cytotoxicity and activity against Staphylococcus aureus (ATCC 6538).
Unfortunately, no antimicrobial activity was detected at the tested concentrations (data not shown).
Compound 2 was indeed not tested for biological activity due to its low purity (<75%). Additionally,
as shown in Figure 4, compound 3 was found to be cytotoxic to HaCaT cells at a concentration
of 10 µg/mL (cell viability was reduced to ca. 60%), so it was excluded from subsequent testing
for anti-inflammatory activity. It was previously reported that the exomethylene cyclopentanone
moiety is beneficial for anticancer activity on cancer cell lines [16]. The exo-methylene group present in
compound 3 and absent in compounds 1 and 4 may be therefore responsible for the cytotoxicity on the
spontaneously immortalized HaCaT cell line.
Figure 4. Viability of HaCaT cells after 6 h of incubation with compounds 1, 3 and 4. (NS: not significant;
****: p < 0.0001).
Compounds 1 and 4 were tested for potential anti-inflammatory activity by incubating human
keratinocytes with the compounds for 24 hours, followed by stimulation of the cells with poly(I:C).
As shown in Figure 5, poly(I:C) induced a marked elevation in the release of IL-1α (250-fold). Preincubation
with compounds 1 and 4 significantly inhibited the release of IL-1α. These results demonstrate that
two of the new diterpenoids extracted from S. hyssopifolia have anti-IL-1α effects on skin epithelial cells.
Human keratinocytes constitutively synthesize proIL-1α and -β but they do not activate and secrete these
proinflammatory cytokines under normal conditions [17]. Upon activation, IL-1 signalling is involved
in many (auto)-inflammatory skin diseases like psoriasis [18], vitiligo [19] or melanoma [20]. The new
diterpenoids extracted from S. hyssopifolia represent new therapeutic topical agents via the modulation of
IL-1α secretion.
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Figure 5. Anti-inflammatory activity of compounds 1 and 4 in HaCaT cells stimulated by poly(I:C).
Compounds in ethanol were prepared at 1:100 dilution in cell medium to obtain a concentration of 10
µg/mL (***: p < 0.001 compared to cell medium with poly(I:C); ####: p < 0.0001).
3. Materials and Methods
3.1. General Experimental Procedures
Optical rotation was measured at the Na D-line (589.3 nm) with a 5 cm cell at 20 ◦C on a
UniPol L1000 polarimeter (Schmidt + Haensch, Berlin, Germany) in methanol. UV and ECD data
were obtained using a ChirascanTM V100 (Applied Photophysics, Leatherhead, UK) in acetonitrile.
NMR experiments were performed using an Inova 500 MHz spectrometer (Varian, Palo Alto, CA,
USA). Chemical shifts were referenced in ppm to the residual solvent signals (CD3OD, at δH 3.31
and δC 49.00 ppm; CDCl3, at δH 7.26 and δH 77.0 ppm). High-resolution mass spectra were
obtained using a mass spectrometer (HRMS; Agilent 6540, Santa Clara, CA, USA). Preparative liquid
chromatography was performed using a Jasco system (Tokyo, Japan) equipped with a PU-2087 pump
and a UV-2075 detector, while semi-preparative purification was realized using a Waters 2690 system
(Milford, MA, USA) equipped with the UV detector 2487.
3.2. Plant Material
Flowering tops of S. hyssopifolia were collected in the Alps, France, at an altitude of 1300 meters.
Botanical identification of the species was carried out by an ethnobotanist of Laboratoires Clarins.
The samples were protected from direct light and air-dried at room temperature for three days.
Two harvests were carried out (July 2016 and August 2017). After comparing the phytochemical
composition, the harvests were gathered.
3.3. Extraction and Isolation
Dried powder of the aerial parts of S. hyssopifolia (300 g) was successively extracted three
times with a methanol/dichloromethane mixture (1:1, v/v) for 15 min under sonication at room
temperature. The crude extract (27 g) was further fractionated by reversed-phase (C18) vacuum liquid
chromatography (VLC) using a step gradient of H2O/MeOH (100:0, 75:25, 50:50, 25:75, 0:100) followed
by a step gradient of MeOH/DCM (50:50, 0:100) to yield seven fractions (F1: 4.56 g, F2: 3.67 g, F3:
2.76 g, F4: 5.93 g, F5: 5.47 g, F6: 3.33 g, and F7: 0.64 g). The methanolic fraction (F5, m = 860 mg)
was purified by preparative reversed-phase high-performance liquid chromatography with a mixture
of water and acetonitrile (flow: 12 mL/min; solvent A: H2O; solvent B: acetonitrile; gradient: 0–3 min
72% B, 3–15 min 72→ 86% B, 15–20 min 86% B, 20–21 min 86%→ 72% B, 21–25 min 72% B) to obtain 12
peaks (P1→P12). After 1H NMR and MS analyses, only compound 1 was pure enough to be identified
Molecules 2020, 25, 589 8 of 10
(6.43 mg, tR = 11 min). The other compounds were identified after a second purification of peaks 4, 7, and
8 (see supporting information). Peak 4 (37 mg, 50 mg/mL) was subjected to preparative HPLC (column
A, flow: 3.5 mL/min; solvent A: H2O; solvent B: acetonitrile, isocratic 55% B, 31 min) to obtain three
known molecules and compound 2 (2.5 mg, tR = 11.6 min). Peak 7 (3.8 mg, 5 mg/mL) was subjected to
semi-preparative HPLC (system: B, column B, flow: 1 mL/min; solvent A: H2O; solvent B: acetonitrile,
isocratic 47% B, 43 min) to obtain a known molecule and compound 3 (0.99 mg, tR = 33.5 min). Peak
8 (7.5 mg, 5 mg/mL) was subjected to semi-preparative HPLC (system: B, column B, flow: 1 mL/min;
solvent A: H2O; solvent B: acetonitrile, isocratic 49% B, 40 min) to yield compound 4 (0.53 mg, tR = 34
min).
3.4. Computational Details
All QM calculations were carried out using Gaussian 16. The GMMX package was used for the
conformational analysis (force field: MMFF94). TD DFT calculations were performed using the B3LYP
method at the 6-31G(d) level for 20 excited states. GaussView 6.0 was used to plot the ECD spectra.
3.5. Cell Experiments
HaCaT cells (spontaneously transformed human keratinocytes) were obtained from Cell Lines
Service (CLS; Eppelheim, Germany). The cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM; Gibco, France) supplemented with 10% fetal bovine serum, 2 mM glutamine, 50 IU/mL
penicillin, and 50 IU/mL streptomycin (Gibco) at 5% CO2 and 37 ◦C. When the HaCaT cells
reached confluency, they were dispersed using trypsin and counted using a hematimeter. The cell
suspension was diluted to a cell density of 100,000 cells/mL and seeded in 96-well microplates for
24 h. The compounds in ethanol were prepared at 1:100 dilution in culture medium and incubated for
24 h. Epigallocatechin gallate (EGCG) at 10 µg/mL was used as an anti-inflammatory control [21].
3.6. Cell Viability Evaluation
A cell viability assay was carried out using the resazurin salt assay. Briefly, after incubating the
cells with compounds 1–4, the medium was removed, and 200 µL of resazurin solution (9 mg/mL,
m/v, Alfa Aesar by Thermo Fisher Scientific, Kandel, Germany) prepared in fresh medium was added
to each well. Following 6 h of incubation, resorufin fluorescence was quantified at the respective
excitation and emission wavelengths of 535 and 600 nm using a Tecan Spark microplate reader. The
percentage of cell viability is expressed in relative fluorescence units (RFU) compared with the control
cells (RFU × 100).
3.7. Interleukin Release Measurement
The potential anti-inflammatory effects of the compounds were evaluated by inducing cytokine release
with poly(I:C), a synthetic analog of viral dsRNA (Sigma-Aldrich, Lyon, France) at 1 µg/mL for 24 hours in
culture medium. The control group was incubated with culture medium. IL-1α release was quantified in
supernatants by ELISA (DuoSet ELISA, R&D Systems, Minneapolis, MN) according to the manufacturer’s
instructions. The absorbance signal was read at 450 nm using a microplate reader (Spark).
3.8. Saponification of Compound 3
K2CO3 (50 mg, 0.36 mmol) was added to a methanol solution (1 mL) of compound 3 (0.53 mg,
0.0015 mmol) at room temperature. The reaction was monitored by TLC and quenched by pouring the
reaction medium into brine. After extraction by ethylacetate, drying over anhydrous sodium sulfate,
concentration under vacuum, and HPLC purification (heptane/ethylacetate, 1:1, v/v), the known
compound ent-3β-7α-dihydroxykaur-16-ene (0.46 mg, 100%) was obtained. The spectral data of
synthetic ent-3β-7α-dihydroxykaur-16-ene were identical to those of the natural compound [15].
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3.9. Statistical Analyses
All statistical analyses were performed using R 3.5.0. Cell samples were analyzed by repeated
measures (n = 3) one-way analysis of variance (ANOVA) followed by Dunnett’s test. Significant
differences for compounds 1–4 are relative to the control and indicated in the results (NS: not significant;
***: p < 0.001; ****: p < 0.0001).
3.10. Hyssopifoliol A (Compound 1)
Light yellow oil; [α]20D −35 (c 0.1, MeOH); CD (acetonitrile) λmax (∆e) 210 (+0.11) nm; 1H and 13C
NMR: see Tables 1 and 2; MS: (+)-HRESIMS m/z 305.2481 (calcd. for C20H33O2, 305.2475, ∆ +1.9 ppm).
3.11. Hyssopifoliol B (Compound 2)
Light yellow oil; [α]20D −26 (c 0.07, MeOH); CD (acetonitrile) λmax (∆e) 210 (+0.06) nm; 1H and 13C
NMR: see Tables 1 and 2; MS: (+)-HRESIMS m/z 287.2361 (calcd. for C20H31O, 287.2369, ∆ -2.8 ppm).
3.12. 3-Acetoxy-ent-3β-7α-dihydroxykaur-16-ene (Compound 3)
Light yellow oil; [α]20D −18 (c 0.06, MeOH); CD (acetonitrile) λmax (∆e) 210 (+0.05) nm; 1H and
13C NMR: see Tables 1 and 2; MS: (+)-HRESIMS m/z 347.2786 (calcd. for C22H34O3Na, 347.2780, ∆ +1.7
ppm).
3.13. 11,12-Didehydrosiderol (Compound 4)
Light yellow oil; [α]20D −23 (c 0.08, MeOH); CD (acetonitrile) λmax (∆e) 215 (+0.07) nm; 1H and 13C
NMR: see Tables 1 and 2; MS: (+)-HRESIMS m/z 285.2251 (calcd. for C20H29O, 285.2221, ∆ +10.5 ppm).
4. Conclusions
The chemical study of S. hyssopifolia led to the isolation and identification of several
diterpenoid compounds. Eight compounds are reported for the first time in this species,
and four are new ent-kauranes, which are designated hyssopifoliol A, hyssopifoliol B,
3-acetoxy-ent-3β-7α-dihydroxykaur-16-ene, and 11,12-didehydrosiderol. Biological tests showed
that two of these molecules have good anti-inflammatory properties. Further biological tests will be
performed to find potential cosmetics applications.
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